Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
September 26, 2025UNC Lineberger leading new trial for anaplastic thyroid cancer2 minutesPlayThe average survival rate is just five to six months after diagnosis, but new trials at UNC Lineberger are bringing some hope for patients....moreShareView all episodesBy September 26, 2025UNC Lineberger leading new trial for anaplastic thyroid cancer2 minutesPlayThe average survival rate is just five to six months after diagnosis, but new trials at UNC Lineberger are bringing some hope for patients....more
The average survival rate is just five to six months after diagnosis, but new trials at UNC Lineberger are bringing some hope for patients.
September 26, 2025UNC Lineberger leading new trial for anaplastic thyroid cancer2 minutesPlayThe average survival rate is just five to six months after diagnosis, but new trials at UNC Lineberger are bringing some hope for patients....more
The average survival rate is just five to six months after diagnosis, but new trials at UNC Lineberger are bringing some hope for patients.